Characteristic attributes in cancer microarrays
暂无分享,去创建一个
Indra Neil Sarkar | S. E. Stanley | Robert DeSalle | Paul J. Planet | David H. Figurski | Mark Siddall | T. E. Bael | R. DeSalle | M. Siddall | I. Sarkar | D. Figurski | P. Planet | T. Bael | S. Stanley
[1] Meland,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[2] A. Giuliani,et al. The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data , 2001, FEBS letters.
[3] J. Hoheisel,et al. Correspondence analysis applied to microarray data , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] I N Sarkar,et al. Systematic analysis of DNA microarray data: ordering and interpreting patterns of gene expression. , 2001, Genome research.
[5] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[6] P. Vyas,et al. Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] Waldmann,et al. Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma. , 2000, Journal of experimental & clinical cancer research : CR.
[8] D. Botstein,et al. Singular value decomposition for genome-wide expression data processing and modeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[10] Gregory R. Grant,et al. Generation of patterns from gene expression data by assigning confidence to differentially expressed genes , 2000, Bioinform..
[11] IA Voutsadakis. Interferon-alpha and the pathogenesis of myeloproliferative disorders , 2000, Medical oncology.
[12] G. Getz,et al. Coupled two-way clustering analysis of gene microarray data. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] G. Sherlock. Analysis of large-scale gene expression data. , 2000, Current opinion in immunology.
[14] J. Jankowski,et al. Aberrant P‐cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia , 2000, The Journal of pathology.
[15] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[16] Alfried P. Vogler,et al. Conservation Genetics at the Species Boundary , 2000 .
[17] D Haussler,et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[19] U. Alon,et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] Zohar Yakhini,et al. Clustering gene expression patterns , 1999, J. Comput. Biol..
[21] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] G. Avvisati,et al. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases , 1998, British journal of haematology.
[24] Thomas Halder,et al. Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells , 1998, Cancer Immunology, Immunotherapy.
[25] J. Zeuthen,et al. The immunogenic properties of human melanomas and melanoma-associated antigens recognized by cytotoxic T lymphocytes. , 1998, Bratislavske lekarske listy.
[26] R. Pöllänen,et al. Multicellular origin of tenascin in skin tumors – an in situ hybridization study , 1997, Journal of cutaneous pathology.
[27] T. Matsuda,et al. Prognostic significance of immunoglobulin heavy chain gene rearrangement in patients with acute myelogenous leukemia , 1997, Leukemia.
[28] H Sugimura,et al. Expression of high‐mobility group‐1 mRNA in human gastrointestinal adenocarcinoma and corresponding non‐cancerous mucosa , 1997, International journal of cancer.
[29] A. Aurias,et al. Isolation of a novel gene from the DiGeorge syndrome critical region with homology to Drosophila gdl and to human LAMC1 genes. , 1996, Human molecular genetics.
[30] P. D. de Jong,et al. Neural cell adhesion molecule distribution in primary and metastatic uveal melanoma. , 1995, Human pathology.
[31] M. Bissonnette,et al. Selective preservation of protein kinase C‐ζ in the chemoprevention of azoxymethane‐induced colonic tumors by piroxicam , 1995, FEBS letters.
[32] Yusuf A. Hannun,et al. Regulation of protein kinase C and role in cancer biology , 1994, Cancer and Metastasis Reviews.
[33] K. Uchida,et al. Amplification of a c-yes-1-related oncogene in canine lymphoid leukemia. , 1994, The Journal of veterinary medical science.
[34] R. DeSalle,et al. Diagnosing Units of Conservation Management , 1994 .
[35] Kevin C. Nixon,et al. Populations, Genetic Variation, and the Delimitation of Phylogenetic Species , 1992 .
[36] R. Phipps,et al. E‐series prostaglandins are potent growth inhibitors for some B lymphomas , 1989, European journal of immunology.
[37] R. Takahashi,et al. c‐yes and bc1‐2 genes located on 18q21.3 in a follicular lymphoma cell line carrying a t(14;18) chromosomal translocation , 1987, International journal of cancer.
[38] M. Slatkin,et al. Private alleles in a partially isolated population. II. Distribution of persistence time and probability of emigration. , 1986, Theoretical population biology.
[39] M. Slatkin,et al. A Quasi-equilibrium theory of the distribution of rare alleles in a subdivided population , 1986, Heredity.
[40] Judith P. Johnson. Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma , 2004, Cancer and Metastasis Reviews.
[41] J. Farris. The Logical Basis of Phylogenetic Analysis , 2004 .
[42] P. Lewis,et al. Phylogenetic systematics turns over a new leaf. , 2001, Trends in ecology & evolution.
[43] Nir Friedman,et al. Tissue classification with gene expression profiles. , 2000 .
[44] D. Khayat,et al. Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expression in advanced melanoma patients. , 2000, Cytokines, cellular & molecular therapy.
[45] C. Demur,et al. Diagnosis of acute basophilic leukemia. , 1999, Leukemia & lymphoma.
[46] Joshua M. Stuart,et al. MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES , 1999 .
[47] D. Brown,et al. A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3beta and EP4. , 1996, Molecular immunology.
[48] Joel Cracraft,et al. Species Concepts and Speciation Analysis , 1983 .
[49] M. Xiong,et al. Biomarker Identification by Feature Wrappers , 2022 .